GlucoPro Insulin Syringes Recalled

Nipro Medical Corporation of Miami Florida has issued a nationwide recall of all <"http://www.yourlawyer.com/practice_areas/defective_medical_devices">GlucoPro Insulin Syringes—except for the GlucoPro syringe specific for use with the Amigo Insulin pump, the U.S. Food and Drug Administration (FDA) just announced.

The recalled syringes may have needles that detach from the syringe. If the needle becomes detached from the syringe during use, it can become stuck in the insulin vial, push back into the syringe, or remain in the skin after injection. Consumers who have GlucoPro Insulin Syringes should stop using and return them to point of sale for reimbursement.

This recall includes all product codes and lot numbers with expiration dates before 2011-11 (November 1, 2011):

• Product Code: JD+01U3008-5C; Lot Number: A08022; Expiry Date: 2011-11

• Product Code: JD+01U3013-5C; Lot Number: A08013; Expiry Date: 2011-06

• Product Code: JD+01U3013-5C; Lot Number: A08017; Expiry Date: 2011-08

• Product Code: JD+01U3108-5C; Lot Number: A08013; Expiry Date: 2011-06

• Product Code: JD+01U3108-5C; Lot Number: A08017; Expiry Date: 2011-08

• Product Code: JD+03U3008-5C; Lot Number: C08022; Expiry Date: 2011-11

• Product Code: JD+03U3013-5C; Lot Number: C08013; Expiry Date: 2011-06

• Product Code: JD+03U3013-5C; Lot Number: C08017; Expiry Date: 2011-08

• Product Code: JD+03U3108-5C; Lot Number: C08013; Expiry Date: 2011-06

• Product Code: JD+03U3108-5C; Lot Number: C08017; Expiry Date: 2011-08

• Product Code: JD+05U3008-5C; Lot Number: B08022; Expiry Date: 2011-11

• Product Code: JD+05U3013-5C; Lot Number: B08013; Expiry Date: 2011-06

• Product Code: JD+05U3013-5C; Lot Number: B08017; Expiry Date: 2011-08

• Product Code: JD+05U3108-5C; Lot Number: B08013; Expiry Date: 2011-06

• Product Code: JD+05U3108-5C; Lot Number: B08017; Expiry Date: 2011-08

Nipro Medical voluntarily recalled the products after learning of the possibility of needle detachment; the FDA has been apprised of this action. To date, no injuries have been reported. The recalled GlucoPro Insulin Syringes were distributed nationwide, including in Puerto Rico.

Nipro Medical is notifying its distributors and customers by fax and email and is arranging for return of all recalled products. Consumers with questions may contact the company at 1-305-599-7174 x249.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program either online at www.fda.gov/medwatch/report.htm; by fax to 1-800-FDA-0178; or by regular mail using postage-paid FDA form 3500 available at: www.fda.gov/MedWatch/getforms.htm that is then mailed to MedWatch/5600 Fishers Lane/Rockville/Maryland/20852-9787.

This entry was posted in Legal News. Bookmark the permalink.


© 2005-2016 Parker Waichman LLP ®. All Rights Reserved.